You are here

ME Therapeutics Holdings Inc.

ME Therapeutics Holdings Inc.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Diversified Industries
Symbol: 
METX
CSE Index: 
Currency: 

ME Therapeutics is an early stage Vancouver based biotechnology company involved in the discovery and development of novel immuno oncology therapeutics targeting immune suppression in cancer. Our main focus is on overcoming the suppressive effects of an important class of immune cells called myeloid cells in order to enhance anti-tumour immunity.

You are here

ME Therapeutics Holdings Inc. (METX)

SEDAR Information

Company Info

Address
177 Robson St.
Vancouver, BC V6B 0N3
Canada
Phone
(236) 516-7714
Email
[email protected]
Website
https://www.metherapeutics.com
Listing date
Thursday, October 12, 2023
Transfer Agent
Odyssey Trust Company

Capitalization

Issued & Outstanding: 
25189438
Reserved for Issuance: 
12058890

Company Officers

Salim Zulifkar Dhanji, Chief Executive Officer
Quinn Martin, Chief Financial Officer
Jamil Kassam, Corporate Secretary

Bulletins

10/10/2023

2023-1016 - New Listing - ME Therapeutics Holdings Inc. (METX)

le 10 octobre/October 2023

The common shares of ME Therapeutics Holdings Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.